Mediverse
Fuses digital medicine with 3D printing to provide personalized clinical solutions spanning preoperative planning, intraoperative navigation, and patient-specific implants.
- CEO / Founder
- Jimmy
- Team Size
- 51-200
- Stage
- Early Stage
- Total Funding
- $5.4M
- Latest Round
- Angel
- Key Investors
- Chengdu Gaoke
Technology & Products
Key Products
Personalized anatomical models; Surgical guides and templates; Patient-specific implants; Preoperative planning software; Intraoperative navigation solutions
Technological Advantage
Proprietary software-to-print workflow for converting medical scan data into patient-specific surgical tools and models, potentially reducing planning time and improving surgical accuracy. The advantage is based on software integration and clinical application expertise, which may be replicable by competitors with similar medical imaging and AM capabilities.
Differentiation
Value Proposition
Reduces surgical risk and improves outcomes through personalized, 3D-printed anatomical models and surgical guides, enabling precise preoperative planning and intraoperative navigation.
How They Differentiate
Focuses on a fully integrated digital medicine platform from scan to surgical application within the Chinese market, compared to broader AM service bureaus or standalone software providers.
Market & Competition
Target Customers
Hospitals, surgeons, medical device manufacturers
Industry Verticals
Healthcare; Medical Devices
Competitors
Materialise; 3D Systems; Stratasys
Growth & Milestones
Growth Metrics
Revenue grew 40% YoY to $12M; 500+ customers
Major Milestones
Company founded in 2025; Completed Angel funding round in April 2025
Notable Customers
Boeing